ACNP - Italian Periodicals Catalogue

AAAAAA

ITA
ENG

Results: 1-25 | 26-49 |

Results: 26-49/49

A PHASE-III RANDOMIZED STUDY OF ORAL VERAPAMIL AS A CHEMOSENSITIZER TO REVERSE DRUG-RESISTANCE IN PATIENTS WITH REFRACTORY MYELOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY

Authors: DALTON WS CROWLEY JJ SALMON SS GROGAN TM LAUFMAN LR WEISS GR BONNET JD

Citation: Ws. Dalton et al., A PHASE-III RANDOMIZED STUDY OF ORAL VERAPAMIL AS A CHEMOSENSITIZER TO REVERSE DRUG-RESISTANCE IN PATIENTS WITH REFRACTORY MYELOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Cancer, 75(3), 1995, pp. 815-820

A NOVEL ANTIGEN DETECTED BY THE CBF.78 ANTIBODY FURTHER DISTINGUISHESANAPLASTIC LARGE-CELL LYMPHOMA FROM HODGKINS-DISEASE

Authors: ALSAATI T TKACZUK J KRISSANSEN G PRINT C PILERI S RALFKIAER E GROGAN TM MEGGETTO F DELSOL G

Citation: T. Alsaati et al., A NOVEL ANTIGEN DETECTED BY THE CBF.78 ANTIBODY FURTHER DISTINGUISHESANAPLASTIC LARGE-CELL LYMPHOMA FROM HODGKINS-DISEASE, Blood, 86(7), 1995, pp. 2741-2746

A CLINICAL ANALYSIS OF 2 INDOLENT LYMPHOMA ENTITIES - MANTLE CELL LYMPHOMA AND MARGINAL ZONE LYMPHOMA (INCLUDING THE MUCOSA-ASSOCIATED LYMPHOID-TISSUE AND MONOCYTOID B-CELL SUBCATEGORIES) - A SOUTHWEST-ONCOLOGY-GROUP STUDY

Authors: FISHER RI DAHLBERG S NATHWANI BN BANKS PM MILLER TP GROGAN TM

Citation: Ri. Fisher et al., A CLINICAL ANALYSIS OF 2 INDOLENT LYMPHOMA ENTITIES - MANTLE CELL LYMPHOMA AND MARGINAL ZONE LYMPHOMA (INCLUDING THE MUCOSA-ASSOCIATED LYMPHOID-TISSUE AND MONOCYTOID B-CELL SUBCATEGORIES) - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Blood, 85(4), 1995, pp. 1075-1082

LYMPHOMA CLASSIFICATION PROPOSAL - CLARIFICATION

Authors: HARRIS NL JAFFE ES STEIN H BANKS PM CHAN JKC CLEARY ML DELSOL G DEWOLFPEETERS C FALINI B GATTER KC GROGAN TM ISAACSON PG KNOWLES DM MASON DY MULLERHERMELINK HK PILERI SA PIRIS MA RALFKIAER E WARNKE RA

Citation: Nl. Harris et al., LYMPHOMA CLASSIFICATION PROPOSAL - CLARIFICATION, Blood, 85(3), 1995, pp. 857-860

A REVISED EUROPEAN-AMERICAN CLASSIFICATION OF LYMPHOID NEOPLASMS PROPOSED BY THE INTERNATIONAL LYMPHOMA STUDY-GROUP - A SUMMARY VERSION

Authors: CHAN JKC BANKS PM CLEARY ML DELSOL G DEWOLFPEETERS C FALINI B GATTER KC GROGAN TM HARRIS NL ISAACSON PG JAFFE ES KNOWLES DM MASON DY MULLERHERMELINK HK PILERI SA PIRIS MA RALFKIAER E STEIN H WARNKE RA

Citation: Jkc. Chan et al., A REVISED EUROPEAN-AMERICAN CLASSIFICATION OF LYMPHOID NEOPLASMS PROPOSED BY THE INTERNATIONAL LYMPHOMA STUDY-GROUP - A SUMMARY VERSION, American journal of clinical pathology, 103(5), 1995, pp. 543-560

THE PRESENCE OF BCL-1 AND BCL-2 GENE REARRANGEMENTS IN DIFFUSE SMALL CLEAVED-CELL LYMPHOMA - A DISEASE WITH DIVERSE MOLECULAR AND IMMUNOPHENOTYPIC FINDINGS

Authors: LEITH CP WILLMAN CL SPIER CM MILLER TP GROGAN TM

Citation: Cp. Leith et al., THE PRESENCE OF BCL-1 AND BCL-2 GENE REARRANGEMENTS IN DIFFUSE SMALL CLEAVED-CELL LYMPHOMA - A DISEASE WITH DIVERSE MOLECULAR AND IMMUNOPHENOTYPIC FINDINGS, Diagnostic molecular pathology, 3(3), 1994, pp. 178-183

A PHASE-III COMPARISON OF CHOP VS M-BACOD VS PROMACE-CYTABOM VS MACOP-B IN PATIENTS WITH INTERMEDIATE-GRADE OR HIGH-GRADE NON-HODGKINS-LYMPHOMA - RESULTS OF SWOG-8516 (INTERGROUP 0067), THE NATIONAL HIGH-PRIORITY LYMPHOMA STUDY

Authors: FISHER RI GAYNOR ER DAHLBERG S OKEN MM GROGAN TM MIZE EM GLICK JH COLTMAN CA MILLER TP

Citation: Ri. Fisher et al., A PHASE-III COMPARISON OF CHOP VS M-BACOD VS PROMACE-CYTABOM VS MACOP-B IN PATIENTS WITH INTERMEDIATE-GRADE OR HIGH-GRADE NON-HODGKINS-LYMPHOMA - RESULTS OF SWOG-8516 (INTERGROUP 0067), THE NATIONAL HIGH-PRIORITY LYMPHOMA STUDY, Annals of oncology, 5, 1994, pp. 190000091-190000095

COMBINATION CHEMOTHERAPY, GLUCOCORTICOIDS, AND INTERFERON-ALFA IN THETREATMENT OF MULTIPLE-MYELOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY

Authors: SALMON SE CROWLEY JJ GROGAN TM FINLEY P PUGH RP BARLOGIE B

Citation: Se. Salmon et al., COMBINATION CHEMOTHERAPY, GLUCOCORTICOIDS, AND INTERFERON-ALFA IN THETREATMENT OF MULTIPLE-MYELOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 12(11), 1994, pp. 2405-2414

A PROPOSAL FOR CLASSIFICATION OF LYMPHOID NEOPLASMS (BY THE INTERNATIONAL LYMPHOMA STUDY-GROUP)

Authors: CHAN JKC BANKS PM CLEARY ML DELSOL G DEWOLFPEETERS C FALINI B GATTER KC GROGAN TM HARRIS NL ISAACSON PG JAFFE BS KNOWLES DM MASON DY MULLERHERMELINK HK PILERI SA PIRIS MA RALFKIAER E STEIN H WARNKE RA

Citation: Jkc. Chan et al., A PROPOSAL FOR CLASSIFICATION OF LYMPHOID NEOPLASMS (BY THE INTERNATIONAL LYMPHOMA STUDY-GROUP), Histopathology, 25(6), 1994, pp. 517-536

ANALYSIS OF THE P53 GENE IN HUMAN PRECANCEROUS ACTINIC KERATOSIS LESIONS AND SQUAMOUS-CELL CANCERS

Authors: NELSON MA EINSPAHR JG ALBERTS DS BALFOUR CA WYMER JA WELCH KL SALASCHE SJ BANGERT JL GROGAN TM BOZZO PO

Citation: Ma. Nelson et al., ANALYSIS OF THE P53 GENE IN HUMAN PRECANCEROUS ACTINIC KERATOSIS LESIONS AND SQUAMOUS-CELL CANCERS, Cancer letters, 85(1), 1994, pp. 23-29

RELATIONSHIP OF P-GLYCOPROTEIN (PGP) TO KARYOTYPE, AGE, AML TYPE, SURFACE PHENOTYPE AND TREATMENT OUTCOME IN ACUTE MYELOID-LEUKEMIA (AML)

Authors: SAMDANI A GLINSMANNGIBSON BJ GRIMM MA VIJAPURKAR U SPIER CS GROGAN TM LIST AF

Citation: A. Samdani et al., RELATIONSHIP OF P-GLYCOPROTEIN (PGP) TO KARYOTYPE, AGE, AML TYPE, SURFACE PHENOTYPE AND TREATMENT OUTCOME IN ACUTE MYELOID-LEUKEMIA (AML), Experimental hematology, 22(8), 1994, pp. 761-761

NODULAR LYMPHOCYTE PREDOMINANCE HODGKINS-DISEASE - A DISTINCT CLINICOPATHOLOGICAL ENTITY

Authors: MASON DY BANKS PM CHAN J CLEARY ML DELSOL G PEETERS CD FALINI B GATTER K GROGAN TM HARRIS NL ISAACSON PG JAFFE ES KNOWLES DM MULLERHERMELINK HK PILERI S RALFKIAER E STEIN H WARNKE R

Citation: Dy. Mason et al., NODULAR LYMPHOCYTE PREDOMINANCE HODGKINS-DISEASE - A DISTINCT CLINICOPATHOLOGICAL ENTITY, The American journal of surgical pathology, 18(5), 1994, pp. 526-530

CD56 - A DETERMINANT OF EXTRAMEDULLARY AND CENTRAL-NERVOUS-SYSTEM (CNS) INVOLVEMENT IN ACUTE MYELOID-LEUKEMIA (AML)

Authors: SCOTT AA KOPECKY KJ GROGAN TM HEAD DR TROY FA MULLEN J YE J APPELBAUM FR THEIL KS WILLMAN CL

Citation: Aa. Scott et al., CD56 - A DETERMINANT OF EXTRAMEDULLARY AND CENTRAL-NERVOUS-SYSTEM (CNS) INVOLVEMENT IN ACUTE MYELOID-LEUKEMIA (AML), Laboratory investigation, 70(1), 1994, pp. 10000120-10000120

A REVISED EUROPEAN-AMERICAN CLASSIFICATION OF LYMPHOID NEOPLASMS - A PROPOSAL FROM THE INTERNATIONAL LYMPHOMA STUDY-GROUP

Citation: Nl. Harris et al., A REVISED EUROPEAN-AMERICAN CLASSIFICATION OF LYMPHOID NEOPLASMS - A PROPOSAL FROM THE INTERNATIONAL LYMPHOMA STUDY-GROUP, Blood, 84(5), 1994, pp. 1361-1392

HLA-DR-, CD33- MYELOID(, CD56+, CD16)NATURAL KILLER-CELL ACUTE-LEUKEMIA - A PREVIOUSLY UNRECOGNIZED FORM OF ACUTE-LEUKEMIA POTENTIALLY MISDIAGNOSED AS FRENCH-AMERICAN-BRITISH ACUTE MYELOID LEUKEMIA-M3/

Authors: SCOTT AA HEAD DR KOPECKY KJ APPELBAUM FR THEIL KS GREVER MR CHEN IM WHITTAKER MH GRIFFITH BB LICHT JD WAXMAN S WHALEN MM BANKHURST AD RICHTER LC GROGAN TM WILLMAN CL

Citation: Aa. Scott et al., HLA-DR-, CD33- MYELOID(, CD56+, CD16)NATURAL KILLER-CELL ACUTE-LEUKEMIA - A PREVIOUSLY UNRECOGNIZED FORM OF ACUTE-LEUKEMIA POTENTIALLY MISDIAGNOSED AS FRENCH-AMERICAN-BRITISH ACUTE MYELOID LEUKEMIA-M3/, Blood, 84(1), 1994, pp. 244-255

P-GLYCOPROTEIN EXPRESSION AND FUNCTION IN CIRCULATING BLOOD-CELLS FROM NORMAL VOLUNTEERS

Authors: KLIMECKI WT FUTSCHER BW GROGAN TM DALTON WS

Citation: Wt. Klimecki et al., P-GLYCOPROTEIN EXPRESSION AND FUNCTION IN CIRCULATING BLOOD-CELLS FROM NORMAL VOLUNTEERS, Blood, 83(9), 1994, pp. 2451-2458

PROGNOSTIC-SIGNIFICANCE OF THE KI-67 ASSOCIATED PROLIFERATIVE ANTIGENIN AGGRESSIVE NON-HODGKINS-LYMPHOMAS - A PROSPECTIVE SOUTHWEST-ONCOLOGY-GROUP TRIAL

Authors: MILLER TP GROGAN TM DAHLBERG S SPIER CM BRAZIEL RM BANKS PM FOUCAR K KJELDSBERG CR LEVY N NATHWANI BN SCHNITZER B TUBBS RR GAYNOR ER FISHER RI

Citation: Tp. Miller et al., PROGNOSTIC-SIGNIFICANCE OF THE KI-67 ASSOCIATED PROLIFERATIVE ANTIGENIN AGGRESSIVE NON-HODGKINS-LYMPHOMAS - A PROSPECTIVE SOUTHWEST-ONCOLOGY-GROUP TRIAL, Blood, 83(6), 1994, pp. 1460-1466

LIGAND-BINDING TO 4-ATOM-LINKED CAPPED PORPHYRINS

Authors: BAG N GROGAN TM MAGDE D SLEBODNICK C JOHNSON MR IBERS JA

Citation: N. Bag et al., LIGAND-BINDING TO 4-ATOM-LINKED CAPPED PORPHYRINS, Journal of the American Chemical Society, 116(26), 1994, pp. 11833-11839

NCAM (CD56)-POSITIVE MALIGNANT-LYMPHOMA

Authors: KERN WF SPIER CM MILLER TP GROGAN TM

Citation: Wf. Kern et al., NCAM (CD56)-POSITIVE MALIGNANT-LYMPHOMA, Leukemia & lymphoma, 12(1-2), 1993, pp. 1

MULTIDRUG-RESISTANCE IN LYMPHOMAS

Authors: DALTON WS MILLER TP GROGAN TM

Citation: Ws. Dalton et al., MULTIDRUG-RESISTANCE IN LYMPHOMAS, Journal of cellular biochemistry, 1993, pp. 257-257

IMMUNOBIOLOGICAL CORRELATES OF PROGNOSIS IN LYMPHOMA

Authors: GROGAN TM MILLER TP

Citation: Tm. Grogan et Tp. Miller, IMMUNOBIOLOGICAL CORRELATES OF PROGNOSIS IN LYMPHOMA, Seminars in oncology, 20(5), 1993, pp. 58-74

NCAM AND TUMORIGENICITY OF HUMAN MULTIPLE-MYELOMA IN SCID MICE

Authors: GUPTILL VA HANNEMAN E GROGAN TM HERSH EM

Citation: Va. Guptill et al., NCAM AND TUMORIGENICITY OF HUMAN MULTIPLE-MYELOMA IN SCID MICE, The Journal of immunology, 150(8), 1993, pp. 311-311

NON-P-GLYCOPROTEIN (PGP) MEDIATED MULTIDRUG-RESISTANCE (MDR) - IDENTIFICATION OF A NOVEL DRUG-RESISTANCE PHENOTYPE WITH PROGNOSTIC RELEVANCE IN ACUTE MYELOID-LEUKEMIA (AML)

Authors: LIST AF SPIER CS ABBASZADEGAN M GROGAN TM GREER JP WOLFF SN SCHEPER RJ DALTON WS

Citation: Af. List et al., NON-P-GLYCOPROTEIN (PGP) MEDIATED MULTIDRUG-RESISTANCE (MDR) - IDENTIFICATION OF A NOVEL DRUG-RESISTANCE PHENOTYPE WITH PROGNOSTIC RELEVANCE IN ACUTE MYELOID-LEUKEMIA (AML), Blood, 82(10), 1993, pp. 10000443-10000443

QUANTITATIVE POLYMERASE CHAIN-REACTION ANALYSIS OF MDR1 MESSENGER-RNAIN MULTIPLE-MYELOMA CELL-LINES AND CLINICAL SPECIMENS

Authors: FUTSCHER BW BLAKE LL GERLACH JH GROGAN TM DALTON WS

Citation: Bw. Futscher et al., QUANTITATIVE POLYMERASE CHAIN-REACTION ANALYSIS OF MDR1 MESSENGER-RNAIN MULTIPLE-MYELOMA CELL-LINES AND CLINICAL SPECIMENS, Analytical biochemistry, 213(2), 1993, pp. 414-421

Risultati: 1-25 | 26-49 |